-
In patients with multiple cardiovascular risk factors, daily treatment with n-3 fatty acids did not reduce cardiovascular mortality and morbidity.
-
The impression is acute infero-posterior infarction, with possible lateral and right ventricular involvement. In most patients, the right coronary artery (RCA) supplies the right ventricle and posterior and inferior walls of the left ventricle.
-
-
The fda has approved a higher dose of the rivastigmine transdermal system (13.3 mg/24 hours) for the treatment of Alzheimer's disease (AD). Lower-dose patches were previously approved for mild-to-moderate disease. Rivastigamine is a reversible acetylcholinesterase inhibitor. The transdermal system is marketed by Novartis as Exelon.
-
A recently published study by investigators led by Clostridium difficile expert Dale Gerding, MD, found that soap and water hand washing widely recommended to remove the spore-forming pathogen is surprisingly ineffective.
-
Dr. Baron is a stockholder for Cepheid, and Immunogenetics, is Director of Medical Affairs for Cepheid, and is on the Scientific Advisory Board for OpGen, Immunogenetics, and NanoMR. She is co-founder of the Diagnostic Microbiology Development Program (www.dmdp.org), a non-profit organization that does laboratory capacity building in the developing world.
-
The dramatic reduction of Clostridium difficile infections (CDI) in hospitals in the United Kingdom is putting considerable pressure on American infection preventionists and health care epidemiologists to follow suit with similar success.
-
-
Despite increased infection prevention efforts in many hospitals, Clostridium difficile infection (CDI) remains a persistent threat to patient safety, according to a new survey of infection preventionists by the Association for Professionals in Infection Control and Epidemiology (APIC).
-
Despite better compliance with hand hygiene and screening, use of isolation, and other techniques, ICUs remain notorious breeding grounds for hospital-acquired infections. A universal decolonization strategy reduces the total number of ICU bloodborne infections.
